Advanced BioDesign
1 known investors
Advanced BioDesign is a clinical-stage French biotechnology company developing small-molecule ALDH1 enzyme inhibitors to overcome drug resistance in chemotherapy-resistant cancers. Its work targets oncology indications such as acute myeloid leukemia, non-small cell lung cancer, and melanoma, alongside a companion diagnostic to stratify patients.
Investors Β· 1
Frequently asked questions
- What does Advanced BioDesign do?
- Advanced BioDesign is a clinical-stage French biotechnology company developing small-molecule ALDH1 enzyme inhibitors to overcome drug resistance in chemotherapy-resistant cancers. Its work targets oncology indications such as acute myeloid leukemia, non-small cell lung cancer, and melanoma, alongside a companion diagnostic to stratify patients.
- Who are Advanced BioDesign's investors?
- Advanced BioDesign's investors include Xerys.